Insiders · HOOK

HOOK insider transactions

HOOKIPA Pharma Inc. (HOOK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

HOOK insiders

Everyone who has filed a Form 3, 4, 5 or 144 at HOOKIPA Pharma Inc., latest first. Follow anyone to get their next filing.

• Malte PetersChief Executive Officer, Director, since January 2023-$47.5K
• Mary Theresa CoelhoEVP and CFO, Director, since April 2023-$12.5K
• Sean A CassidyDirector, since July 2024
• David Ross KaufmanDirector
• Jan van de WinkelDirector
• Julie O'NeillDirector
• Timothy P. ReillyDirector, since April 2022
• Klaus OrlingerChief Scientific Officer
• Jorn AldagChief Executive Officer, Director+$17.1K
• Reinhard KanderaChief Financial Officer, Director+$21.3K
• Mark WinderlichChief Development Officer, since April 2024
• Roman NecinaChief Operations Officer
• Gilead Sciences, Inc.10% owner, since February 2022
• Katia SchliengerOfficer, since March 2023
• Christine D. BakerOfficer, since March 2021
• Igor MatushanskyOfficer-$37.2K
• Michael Aaron KellyDirector
• Graziano SeghezziDirector
• Christoph LengauerDirector
• Sofinnova Capital Vi Fcpr10% owner-$9.47M

Recent Form 3, 4, and 5 filings for HOOK

• 397d
  Chief Executive Officer Peters Malte sold $20,684 worth of shares (25,172 units at $0.82), decreasing direct ownership by 32% to 54,347 units (SEC Form 4)

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 475d
  Chief Executive Officer Peters Malte sold $26,842 worth of shares (29,176 units at $0.92), decreasing direct ownership by 27% to 79,519 units (SEC Form 4)

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 475d
  EVP and CFO Coelho Mary Theresa sold $12,520 worth of shares (13,609 units at $0.92), decreasing direct ownership by 19% to 56,266 units (SEC Form 4)

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 839d
  EVP and CFO Coelho Mary Theresa was granted 69,875 shares (SEC Form 4)

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 839d
  Chief Executive Officer Peters Malte was granted 108,695 shares (SEC Form 4)

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 839d
  SEC Form 4 filed by Director Cassidy Sean A

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 839d
  SEC Form 3 filed by new insider Cassidy Sean A

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director Peters Malte

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director Kaufman David Ross

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director Van De Winkel Jan

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director Coelho Mary Theresa

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director O'Neill Julie

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 875d
  SEC Form 4 filed by Director Reilly Timothy P.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 937d
  SEC Form 4 filed by Orlinger Klaus

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 937d
  SEC Form 4 filed by Kandera Reinhard

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 937d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 937d
  SEC Form 4 filed by Winderlich Mark

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 937d
  SEC Form 4 filed by Necina Roman

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 943d
  SEC Form 3 filed by new insider Winderlich Mark

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1054d
  New insider Gilead Sciences, Inc. claimed ownership of 18,759,465 shares (SEC Form 3)

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1176d
  SEC Form 4: Kandera Reinhard bought $5,075 worth of shares (7,000 units at $0.72), increasing direct ownership by 19% to 43,092 units

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1181d
  SEC Form 4: Kandera Reinhard bought $5,712 worth of shares (8,000 units at $0.71), increasing direct ownership by 28% to 36,092 units

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1218d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1222d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1224d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1226d
  SEC Form 4 filed by Kandera Reinhard

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by Peters Malte

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by Reilly Timothy P.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by O'Neill Julie

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by Van De Winkel Jan

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by Kaufman David Ross

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1250d
  SEC Form 4 filed by Coelho Mary Theresa

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Orlinger Klaus

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Necina Roman

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Schlienger Katia

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Baker Christine D.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Kandera Reinhard

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 3: New insider Schlienger Katia claimed ownership of 1,300 shares

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1302d
  SEC Form 3 filed by new insider Peters Malte

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1316d
  SEC Form 3 filed by new insider Coelho Mary Theresa

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Van De Winkel Jan

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Reilly Timothy P.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Orlinger Klaus

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by O'Neill Julie

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Necina Roman

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Matushansky Igor

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Kelly Michael Aaron

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Kaufman David Ross

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Kandera Reinhard

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Baker Christine D.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1593d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Orlinger Klaus

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Necina Roman

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Matushansky Igor

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Kandera Reinhard

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Baker Christine D.

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 4 filed by Aldag Jorn

  4 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1665d
  SEC Form 3 filed by new insider Reilly Timothy P.

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)
• 1727d
  SEC Form 3: New insider Gilead Sciences Inc claimed ownership of 3,759,465 shares

  3 - HOOKIPA Pharma Inc. (0001760542) (Issuer)